Bio-distribution and longevity of mesenchymal stromal cell derived membrane particles
Open Access
- 6 September 2022
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 350, 642-651
Abstract
No abstract availableKeywords
Funding Information
- TKI (LSHM18005)
This publication has 57 references indexed in Scilit:
- MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune ModulationStem Cells International, 2013
- Mesenchymal stem cells: a new trend for cell therapyActa Pharmacologica Sinica, 2013
- Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I StudyStem Cells Translational Medicine, 2013
- Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantationJournal of Zhejiang University-SCIENCE B, 2012
- Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusionFrontiers in Immunology, 2012
- Skyline: an open source document editor for creating and analyzing targeted proteomics experimentsBioinformatics, 2010
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- GAGE: generally applicable gene set enrichment for pathway analysisBMC Bioinformatics, 2009
- Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular InjuryJournal of the American Society of Nephrology, 2009
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008